TrialAmerican journal of hematology2018

Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia.

Roland B Walter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.